comparemela.com

Latest Breaking News On - National pharmaceutical regulatory division - Page 1 : comparemela.com

MoH, Singapore s Health Sciences Authority sign MoU to facilitate pharmaceutical regulatory information exchange

PUTRAJAYA, May 6 The re-signing of a memorandum of understanding (MoU) between the Ministry of Health (MoH) and the Health Sciences Authority (HSA) of Singapore facilitates.

Pharmacy services norhalizaa halimNational pharmaceutical regulatory divisionMinistry of health moHealth sciences authorityMinistry of healthGood regulatory practiceSenior directorPharmacy services norhalizaHealth ministryHealth science authority hsaMalaysia singapore tiesInformation exchange

Health Ministry: Applications for CTIL, CTX for first in human clinical trials now open

PUTRAJAYA, April 5 The Clinical Trial Import Licence (CTIL) and Clinical Trial Exemption for Unregistered Products for Clinical Trial Purposes (CTX) for “first in human”.

Norhalizaa halimMinistry of healthDrug control authorityNational pharmaceutical regulatory divisionAccreditation programmeClinical trial import licenceClinical trial exemptionUnregistered productsClinical trial purposesMalaysian guidelineClinical trial import licenseSouth east asiaSarawak general hospitalPhasei unit inspectionHealth ministryFirst in human clinical trials

Antiretroviral therapy drugs fall under Poisons Act, warns health ministry

PETALING JAYA: Antiretroviral therapy drugs are categorised as controlled substances regulated by the Poisons Act 1952, says the health ministry.

Malaysia generalNational pharmaceutical regulatory divisionPoisons actDaily express

MOH Issues Warning To Individual Who Attempted To Sell Subsidised Meds On Twitter

An investigation was conducted by the Ministry of Health's Pharmacy Enforcement Division in collaboration with the Kedah Health Department.

Penjualan ubat terkawalKedah health departmentNational pharmaceutical regulatory divisionPharmacy enforcement divisionMinistry of healthDoctors react to twitter userAttempt at selling subsidizedHighly active antiretroviral therapyKedah healthPenjualan ubat terkawal di aplikasiPoisons act

Forest Research Institute aims to commercialise herbal products worth RM30m by 2025

Kuala Lumpur, Sept 12 The Forest Research Institute of Malaysia (Frim), via its Herbal Technology Centre (HTC), aims to commercialise products worth RM30 million by 2025,.

Kuala lumpurNational pharmaceutical regulatory divisionTechnology centreForest research institute of malaysia frimForest research instituteHerbal technology centreMalaysia planGood manufacturing practicesHazard analysis critical control pointHalal confirmation certificateOriginal equipment manufacturerHerbal products

vimarsana © 2020. All Rights Reserved.